Site Vision Incorporated (OTCBB: INSV) today announced that it has sponsored research being presented in five scientific posters at the 2013 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held from May 5-9, 2013, in Seattle, Washington. The presentations cover data generated from the company’s clinical programs for the treatment of blepharitis and ocular pain and inflammation, multiple preclinical candidates and InSite’s DuraSite 2 platform technology.